About the "CCDE 2025"
From November 14 to 27, 2025, academic exchanges in the field of digestive tract disease diagnosis and treatment entered an intensive period. Chuangxiang Medicine accurately seized the opportunity for industry exchanges and successively debuted at nine important academic events in Nanjing (Jiangsu), Hunan, Tianjin, Hainan, Sichuan, Guizhou, Liaoning, Lianyungang (Jiangsu) and Shanghai. This series of academic activities covers six major regions: East China, Central China, North China, South China, Southwest China and Northeast China, gathering top experts and scholars in domestic fields such as gastroenterology and endoscopic diagnosis and treatment. It is an authoritative and influential academic exchange platform in the industry.
To fully convey technological achievements and clinical value, Chuangxiang Medicine has built a diversified display and exchange scenario around the core demand of early screening and treatment of digestive tract diseases. In the technology exhibition area, its independently developed core products such as digestive tract disease screening systems and endoscopic assisted diagnosis and treatment equipment were all on display. Through dynamic demonstrations, physical displays and other methods, the technical advantages of the products in precise diagnosis, minimally invasive treatment and other aspects were intuitively presented. Many experts stopped to observe, in-depth discussed key issues such as the operational convenience and data accuracy of the equipment with on-site technical personnel, and highly recognized the clinical adaptability of the products.
In the academic report session, the technical experts and clinical consultant team of Chuangxiang Medicine successively shared keynote reports such as "Innovative Application of Early Gastrointestinal Cancer Screening Technology" and "Clinical Practice of Intelligent Solutions for Endoscopic Diagnosis and Treatment" combined with clinical practice cases. Focusing on the pain points and difficulties in clinical diagnosis and treatment, the reports systematically expounded the practical value of Chuangxiang Medicine's technological achievements in improving screening efficiency, reducing missed diagnosis rate and optimizing treatment processes, which aroused widespread resonance among participating experts. In addition, in the surgical practical demonstration session, the team jointly carried out multiple live broadcasts of minimally invasive endoscopic surgeries with experts from cooperative hospitals, real-time demonstrating the precise diagnosis and treatment process completed with the help of its technical equipment. The clear operational field of vision and efficient diagnosis and treatment effect won bursts of applause from the on-site audience.
This academic journey across nine regions not only enabled Chuangxiang Medicine's cutting-edge technological achievements to undergo
in-depth inspection by industry experts, but also built a cross-regional academic exchange bridge. Through full interaction with experts from various regions, Chuangxiang Medicine further clarified the direction of clinical needs and accumulated valuable experience for the continuous iteration of technology. As an innovative enterprise focusing on the field of digestive tract disease diagnosis and treatment, Chuangxiang Medicine's concentrated appearance this time not only provides clinical practice with innovative and practical solutions for early screening and treatment, but also helps promote the standardization and intelligent development of domestic digestive tract disease diagnosis and treatment technology, injecting new momentum into improving the national digestive tract health level.
